J. Shay and S. Bacchetti, A survey of telomerase activity in human cancer, European Journal of Cancer, vol.33, issue.5, pp.787-91, 1990.
DOI : 10.1016/S0959-8049(97)00062-2

D. Hanahan and R. Weinberg, Hallmarks of Cancer: The Next Generation, Cell, vol.144, issue.5, pp.646-74, 2011.
DOI : 10.1016/j.cell.2011.02.013

A. Poonepalli, B. Banerjee, K. Ramnarayanan, N. Palanisamy, T. Putti et al., Telomere-mediated genomic instability and the clinico-pathological parameters in breast cancer, Genes, Chromosomes and Cancer, vol.13, issue.12, pp.1098-109, 2008.
DOI : 10.1111/j.1349-7006.2002.tb02166.x

L. Lu, C. Zhang, G. Zhu, M. Irwin, H. Risch et al., Telomerase expression and telomere length in breast cancer and their associations with adjuvant treatment and disease outcome, Breast Cancer Research, vol.24, issue.3, p.56, 2011.
DOI : 10.1186/1471-2407-6-206
URL : https://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2893?site=breast-cancer-research.biomedcentral.com

M. Gay-bellile, P. Romero, A. Cayre, L. Véronèse, M. Privat et al., ERCC1 and telomere status in breast tumours treated with neoadjuvant chemotherapy and their association with patient prognosis, The Journal of Pathology: Clinical Research, vol.7, issue.Suppl 1, pp.234-280, 2016.
DOI : 10.1371/journal.pone.0048670
URL : https://doi.org/10.1002/cjp2.52

T. Liu, X. Yuan, and D. Xu, Cancer-Specific Telomerase Reverse Transcriptase (TERT) Promoter Mutations: Biological and Clinical Implications, Genes, vol.6, issue.7, 2016.
DOI : 10.1371/journal.pone.0052989
URL : http://www.mdpi.com/2073-4425/7/7/38/pdf

K. Wu, C. Grandori, M. Amacker, N. Simon-vermot, A. Polack et al., Direct activation of TERT transcription by c-MYC, Nat Genet, vol.21, pp.220-224, 1999.

Y. Cao, T. Bryan, and R. Reddel, Increased copy number of the TERT and TERC telomerase subunit genes in cancer cells, Cancer Science, vol.24, issue.6, pp.1092-1101, 2008.
DOI : 10.1128/MCB.19.6.3989

W. Hahn and M. Meyerson, Telomerase activation, cellular immortalization and cancer, Annals of Medicine, vol.18, issue.2, pp.123-132, 2001.
DOI : 10.1038/71894

J. Zhu, Y. Zhao, and S. Wang, Chromatin and epigenetic regulation of the telomerase reverse transcriptase gene, Protein & Cell, vol.67, issue.1, pp.22-32, 2010.
DOI : 10.1158/0008-5472.CAN-06-3396

P. Killela, Z. Reitman, Y. Jiao, C. Bettegowda, N. Agrawal et al., TERT promoter mutations occur frequently in gliomas and a subset of tumors derived from cells with low rates of self-renewal, Proceedings of the National Academy of Sciences, vol.360, issue.8
DOI : 10.1056/NEJMoa0808710

J. Vinagre, A. Almeida, H. Pópulo, R. Batista, J. Lyra et al., Frequency of TERT promoter mutations in human cancers, Nature Communications, vol.30, p.2185, 2013.
DOI : 10.1038/onc.2010.512

F. Huang, E. Hodis, M. Xu, G. Kryukov, L. Chin et al., Highly Recurrent TERT Promoter Mutations in Human Melanoma, Science, vol.38, issue.5, pp.957-966, 2013.
DOI : 10.1038/ng1777
URL : https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4423787/pdf

C. Hsu, N. Hsu, L. Lee, and J. Ko, Ets2 binding site single nucleotide polymorphism at the hTERT gene promoter ??? effect on telomerase expression and telomere length maintenance in non-small cell lung cancer, European Journal of Cancer, vol.42, issue.10, pp.1466-74, 1990.
DOI : 10.1016/j.ejca.2006.02.014

D. Xu, J. Dwyer, H. Li, W. Duan, and J. Liu, Ets2 Maintains hTERT Gene Expression and Breast Cancer Cell Proliferation by Interacting with c-Myc, Journal of Biological Chemistry, vol.58, issue.35, pp.23567-80, 2008.
DOI : 10.1016/j.ejca.2006.02.014
URL : http://www.jbc.org/content/283/35/23567.full.pdf

C. Park, S. Lee, J. Kim, J. Kim, T. Kim et al., Expression level of <i>hTERT</i> is regulated by somatic mutation and common single nucleotide polymorphism at promoter region in glioblastoma, Oncotarget, vol.5, issue.10, pp.3399-407, 1975.
DOI : 10.18632/oncotarget.1975

J. Nabholtz, C. Abrial, M. Mouret-reynier, M. Dauplat, B. Weber et al., Multicentric neoadjuvant phase II study of panitumumab combined with an anthracycline/taxane-based chemotherapy in operable triple-negative breast cancer: identification of biologically defined signatures predicting treatment impact, Annals of Oncology, vol.25, issue.8
DOI : 10.1093/annonc/mdu183

J. Nabholtz, N. Chalabi, N. Radosevic-robin, M. Dauplat, M. Mouret-reynier et al., Multicentric neoadjuvant pilot Phase II study of cetuximab combined with docetaxel in operable triple negative breast cancer, International Journal of Cancer, vol.24, issue.8, pp.2274-80, 2016.
DOI : 10.1016/j.cytogfr.2013.01.005

I. Bièche, C. Noguès, V. Paradis, M. Olivi, P. Bedossa et al., Quantitation of hTERT gene expression in sporadic breast tumors with a real-time reverse transcription-polymerase chain reaction assay, Clin Cancer Res Off J Am Assoc Cancer Res, vol.6, pp.452-461, 2000.

C. Brennan, R. Verhaak, A. Mckenna, B. Campos, H. Noushmehr et al., The Somatic Genomic Landscape of Glioblastoma, Cell, vol.155, issue.2, pp.462-77, 2013.
DOI : 10.1016/j.cell.2013.09.034

M. Labussière, D. Stefano, A. Gleize, V. Boisselier, B. Giry et al., TERT promoter mutations in gliomas, genetic associations and clinico-pathological correlations, British Journal of Cancer, vol.5, issue.10, pp.2024-2056, 2014.
DOI : 10.1007/s13238-010-0014-1

P. Rachakonda, I. Hosen, P. De-verdier, M. Fallah, B. Heidenreich et al., TERT promoter mutations in bladder cancer affect patient survival and disease recurrence through modification by a common polymorphism, Proceedings of the National Academy of Sciences, vol.84, issue.11, pp.17426-17457, 2013.
DOI : 10.1054/bjoc.2001.1823

E. Ko, H. Seo, E. Jung, B. Kim, and G. Jung, The <i>TERT</i> promoter SNP rs2853669 decreases E2F1 transcription factor binding and increases mortality and recurrence risks in liver cancer, Oncotarget, vol.7, issue.1, pp.684-99, 2016.
DOI : 10.18632/oncotarget.6331

I. Hosen, P. Rachakonda, B. Heidenreich, P. De-verdier, C. Ryk et al., Mutations in TERT promoter and FGFR3 and telomere length in bladder cancer
DOI : 10.1002/ijc.29526
URL : http://onlinelibrary.wiley.com/doi/10.1002/ijc.29526/pdf

I. Hosen, P. Rachakonda, B. Heidenreich, R. Sitaram, B. Ljungberg et al., promoter mutations in clear cell renal cell carcinoma, International Journal of Cancer, vol.103, issue.10, pp.2448-52, 2015.
DOI : 10.1073/pnas.0510085103

M. Mosrati, A. Malmström, M. Lysiak, A. Krysztofiak, M. Hallbeck et al., <i>TERT</i> promoter mutations and polymorphisms as prognostic factors in primary glioblastoma, Oncotarget, vol.6, issue.18, pp.16663-73, 2015.
DOI : 10.18632/oncotarget.4389
URL : http://www.impactjournals.com/oncotarget/index.php?journal=oncotarget&page=article&op=download&path%5B%5D=4389&path%5B%5D=12478

M. Mosrati, K. Willander, I. Falk, M. Hermanson, M. Höglund et al., Association between TERT promoter polymorphisms and acute myeloid leukemia risk and prognosis, Oncotarget, vol.6, issue.28, pp.25109-25129, 2015.
DOI : 10.18632/oncotarget.4668
URL : http://www.impactjournals.com/oncotarget/index.php?journal=oncotarget&page=article&op=view&path%5B%5D=4668&path%5B%5D=12873

A. Zhang, C. Zheng, C. Lindvall, M. Hou, J. Ekedahl et al., Frequent amplification of the telomerase reverse transcriptase gene in human tumors, Cancer Res, vol.60, pp.6230-6235, 2000.

H. Xie, T. Liu, N. Wang, V. Björnhagen, A. Höög et al., <i>TERT</i> promoter mutations and gene amplification: Promoting <i>TERT</i> expression in Merkel cell carcinoma, Oncotarget, vol.5, issue.20, pp.10048-57, 2014.
DOI : 10.18632/oncotarget.2491
URL : http://www.impactjournals.com/oncotarget/index.php?journal=oncotarget&page=article&op=download&path%5B%5D=2491&path%5B%5D=4450

C. Zhu, J. Cutz, N. Liu, D. Lau, F. Shepherd et al., Amplification of telomerase (hTERT) gene is a poor prognostic marker in non-small-cell lung cancer, British Journal of Cancer, vol.10, issue.10, pp.1452-1461, 2006.
DOI : 10.1158/1078-0432.CCR-03-0470

A. Zhang, C. Zheng, M. Hou, C. Lindvall, K. Wallin et al., ) gene in cervical carcinomas, Genes, Chromosomes and Cancer, vol.92, issue.3, pp.269-75, 2002.
DOI : 10.1093/jnci/92.9.690

R. Palmqvist, A. Zhang, D. Xu, I. Golovleva, K. Norrback et al., hTERT gene copy number is not associated with hTERT RNA expression or telomerase activity in colorectal cancer, International Journal of Cancer, vol.104, issue.3, pp.395-400, 2005.
DOI : 10.1016/0016-5085(93)90368-M
URL : http://onlinelibrary.wiley.com/doi/10.1002/ijc.21020/pdf

A. Diaz, J. Puig-butillé, C. Muñoz, D. Costa, A. Díez et al., TERT gene amplification is associated with poor outcome in acral lentiginous melanoma, Journal of the American Academy of Dermatology, vol.71, issue.4, pp.839-880, 2014.
DOI : 10.1016/j.jaad.2014.05.035

M. Ruden and N. Puri, Novel anticancer therapeutics targeting telomerase, Cancer Treatment Reviews, vol.39, issue.5, pp.444-56, 2013.
DOI : 10.1016/j.ctrv.2012.06.007

A. Latil, D. Vidaud, A. Valéri, G. Fournier, M. Vidaud et al., htert expression correlates withMYC over-expression in human prostate cancer, International Journal of Cancer, vol.21, issue.2, pp.172-178, 2000.
DOI : 10.1002/(SICI)1097-0215(20000320)89:2<172::AID-IJC12>3.0.CO;2-8

J. Wang, L. Xie, A. S. Beach, D. Hannon, and G. , Myc activates telomerase, Genes & Development, vol.12, issue.12, pp.1769-74, 1998.
DOI : 10.1101/gad.12.12.1769
URL : http://genesdev.cshlp.org/content/12/12/1769.full.pdf

J. Dwyer, H. Li, D. Xu, and J. Liu, Transcriptional Regulation of Telomerase Activity: Roles of the the Ets Transcription Factor Family, Annals of the New York Academy of Sciences, vol.42, issue.1, pp.36-47, 2007.
DOI : 10.1016/S0014-4800(03)00092-3

H. Li, D. Xu, J. Li, M. Berndt, and J. Liu, Transforming Growth Factor ?? Suppresses Human Telomerase Reverse Transcriptase (hTERT) by Smad3 Interactions with c-Myc and the hTERT Gene, Journal of Biological Chemistry, vol.19, issue.35, pp.25588-600, 2006.
DOI : 10.1016/S0092-8674(02)00801-2

C. Koh, E. Khattar, S. Leow, C. Liu, J. Muller et al., Telomerase regulates MYC-driven oncogenesis independent of its reverse transcriptase activity, Journal of Clinical Investigation, vol.125, issue.5, pp.2109-2131, 2015.
DOI : 10.1172/JCI79134DS1
URL : http://www.jci.org/articles/view/79134/files/pdf

Y. Chen, Y. Yang, M. Van-overbeek, J. Donigian, P. Baciu et al., A Shared Docking Motif in TRF1 and TRF2 Used for Differential Recruitment of Telomeric Proteins, Science, vol.64, issue.11, pp.1092-1098, 2008.
DOI : 10.1158/0008-5472.CAN-04-0136

A. Wolfer, S. Ramaswamy, . Myc, and . Metastasis, MYC and Metastasis, Cancer Research, vol.71, issue.6, pp.2034-2041, 2011.
DOI : 10.1158/0008-5472.CAN-10-3776
URL : http://cancerres.aacrjournals.org/content/canres/71/6/2034.full.pdf

A. Wolfer, B. Wittner, D. Irimia, R. Flavin, M. Lupien et al., MYC regulation of a "poor-prognosis" metastatic cancer cell state, Proceedings of the National Academy of Sciences, vol.30, issue.3, pp.3698-703, 2010.
DOI : 10.1016/S1046-2023(03)00032-X

F. Penault-llorca, C. Abrial, I. Raoelfils, A. Cayre, M. Mouret-reynier et al., Comparison of the prognostic significance of Chevallier and Sataloff's pathologic classifications after neoadjuvant chemotherapy of operable breast cancer, Human Pathology, vol.39, issue.8, pp.1221-1229, 2008.
DOI : 10.1016/j.humpath.2007.11.019

D. Poncet, A. Belleville, C. De-roodenbeke, R. De-climens, A. et al., Changes in the expression of telomere maintenance genes suggest global telomere dysfunction in B-chronic lymphocytic leukemia, Blood, vol.111, issue.4, pp.2388-91, 2008.
DOI : 10.1182/blood-2007-09-111245
URL : https://hal.archives-ouvertes.fr/ensl-00781642

L. Véronèse, O. Tournilhac, M. Callanan, N. Prie, F. Kwiatkowski et al., Telomeres and chromosomal instability in chronic lymphocytic leukemia, Leukemia, vol.27, issue.2, pp.490-493, 2013.
DOI : 10.1016/j.ejca.2008.11.014

M. Mitas, K. Mikhitarian, C. Walters, P. Baron, B. Elliott et al., Quantitative real-time RT-PCR detection of breast cancer micrometastasis using a multigene marker panel, International Journal of Cancer, vol.342, issue.2, pp.162-71, 2001.
DOI : 10.1056/NEJM200002243420801

F. Niel, J. Martin, D. Moal, F. Costes, B. Boissier et al., Rapid detection of CFTR gene rearrangements impacts on genetic counselling in cystic fibrosis, Journal of Medical Genetics, vol.41, issue.11, p.118, 2004.
DOI : 10.1136/jmg.2004.022400

C. Pebrel-richard, S. Kemeny, L. Gouas, E. Eymard-pierre, N. Blanc et al., An atypical 0.8??Mb inherited duplication of 22q11.2 associated with psychomotor impairment, European Journal of Medical Genetics, vol.55, issue.11, pp.650-655, 2012.
DOI : 10.1016/j.ejmg.2012.06.014